2004
A Yb:GdVO4 single crystal was grown by the Czochralski process. Its thermal conductivity was measured by photothermal analysis and reached (…)
Consulter 
2004
Abnormal deposition of Abeta (amyloid-beta peptide) is one of the hallmarks of AD (Alzheimer’s disease). This peptide results from the (…)
Consulter
2004
Stroke, the third leading cause of death in industrialised countries, represents a major burden on healthcare authorities. The elucidation of (…)
Consulter
2004
Inflammation has been reported in numerous neurodegenerative disorders such as Parkinson’s disease, stroke and Alzheimer’s disease (AD). In AD, the (…)
Consulter
2004
Tissue-type plasminogen activator (tPA) has been involved in both physiological and pathological glutamatergic-dependent processes, such as synaptic plasticity, seizure, trauma, (…)
Consulter
2004
Tissue-type plasminogen activator (tPA) is available for the treatment of thromboembolic stroke in humans. However, adverse effects of tPA have (…)
Consulter
